These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 14711866)

  • 1. Exhaled nitric oxide in chronically ventilated preterm infants.
    Williams O; Bhat RY; Cheeseman P; Rafferty GF; Hannam S; Greenough A
    Arch Dis Child Fetal Neonatal Ed; 2004 Jan; 89(1):F88-9. PubMed ID: 14711866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants.
    Subhedar NV; Ryan SW; Shaw NJ
    Arch Dis Child Fetal Neonatal Ed; 1997 Nov; 77(3):F185-90. PubMed ID: 9462187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatologists are using much less dexamethasone.
    Shinwell ES; Karplus M; Bader D; Dollberg S; Gur I; Weintraub Z; Arnon S; Gottfreid E; Zaritsky A; Makhoul IR; Reich D; Sirota L; Berger I; Kogan A; Yurman S; Goldberg M; Kohelet D
    Arch Dis Child Fetal Neonatal Ed; 2003 Sep; 88(5):F432-3. PubMed ID: 12937052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of exhaled nitric oxide in pre-term infants with chronic lung disease.
    Roiha HL; Kuehni CE; Zanolari M; Zwahlen M; Baldwin DN; Casaulta C; Nelle M; Frey U
    Eur Respir J; 2007 Feb; 29(2):251-8. PubMed ID: 17050555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac effects of short course dexamethasone in preterm infants.
    Skelton R; Gill AB; Parsons JM
    Arch Dis Child Fetal Neonatal Ed; 1998 Mar; 78(2):F133-7. PubMed ID: 9577285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2014 May; (5):CD001145. PubMed ID: 24825542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. A randomized trial.
    Romagnoli C; Zecca E; Vento G; Maggio L; Papacci P; Tortorolo G
    Pharmacology; 1999 Nov; 59(5):266-74. PubMed ID: 10529659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of dexamethasone on respirator-dependent very-low-birth-weight infants is best predicted by chest X-ray.
    Schrod L; Neuhaus T; Horwitz AE; Speer CP
    Pediatr Radiol; 2001 May; 31(5):332-8. PubMed ID: 11373920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants.
    Rozycki HJ; Byron PR; Elliott GR; Carroll T; Gutcher GR
    Pediatr Pulmonol; 2003 May; 35(5):375-83. PubMed ID: 12687595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA
    Cochrane Database Syst Rev; 2000; (2):CD001145. PubMed ID: 10796251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2014 May; (5):CD001146. PubMed ID: 24825456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung function and exhaled nitric oxide levels in infants developing chronic lung disease.
    Williams O; Dimitriou G; Hannam S; Rafferty GF; Greenough A
    Pediatr Pulmonol; 2007 Feb; 42(2):107-13. PubMed ID: 17186509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of nitric oxide in chronic lung disease.
    Clark PL; Ekekezie II; Kaftan HA; Castor CA; Truog WE
    Arch Dis Child Fetal Neonatal Ed; 2002 Jan; 86(1):F41-5. PubMed ID: 11815547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2003; (1):CD002058. PubMed ID: 12535425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased use of postnatal corticosteroids in extremely preterm infants without increasing chronic lung disease.
    Seth R; Gray PH; Tudehope DI
    Neonatology; 2009; 95(2):172-8. PubMed ID: 18776732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
    Shah V; Ohlsson A; Halliday HL; Dunn MS
    Cochrane Database Syst Rev; 2000; (2):CD001969. PubMed ID: 10796275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease.
    Groneck P; Reuss D; Götze-Speer B; Speer CP
    J Pediatr; 1993 Jun; 122(6):938-44. PubMed ID: 8388949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA
    Cochrane Database Syst Rev; 2000; (2):CD001146. PubMed ID: 10796252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exhaled nitric oxide at school age in prematurely born infants with neonatal chronic lung disease.
    Mieskonen ST; Malmberg LP; Kari MA; Pelkonen AS; Turpeinen MT; Hallman NM; Sovijärvi AR
    Pediatr Pulmonol; 2002 May; 33(5):347-55. PubMed ID: 11948979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.